These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 22480387)

  • 1. Association of common variations in the norepinephrine transporter gene with response to olanzapine-fluoxetine combination versus continued-fluoxetine treatment in patients with treatment-resistant depression: a candidate gene analysis.
    Houston JP; Lau K; Aris V; Liu W; Fijal BA; Heinloth AN; Perlis RH
    J Clin Psychiatry; 2012 Jun; 73(6):878-85. PubMed ID: 22480387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic association study of treatment response with olanzapine/fluoxetine combination or lamotrigine in bipolar I depression.
    Perlis RH; Adams DH; Fijal B; Sutton VK; Farmen M; Breier A; Houston JP
    J Clin Psychiatry; 2010 May; 71(5):599-605. PubMed ID: 20021991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olanzapine/fluoxetine combination in patients with treatment-resistant depression: rapid onset of therapeutic response and its predictive value for subsequent overall response in a pooled analysis of 5 studies.
    Tohen M; Case M; Trivedi MH; Thase ME; Burke SJ; Durell TM
    J Clin Psychiatry; 2010 Apr; 71(4):451-62. PubMed ID: 20361905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.
    Shelton RC; Williamson DJ; Corya SA; Sanger TM; Van Campen LE; Case M; Briggs SD; Tollefson GD
    J Clin Psychiatry; 2005 Oct; 66(10):1289-97. PubMed ID: 16259543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder.
    Thase ME; Corya SA; Osuntokun O; Case M; Henley DB; Sanger TM; Watson SB; Dubé S
    J Clin Psychiatry; 2007 Feb; 68(2):224-36. PubMed ID: 17335320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression.
    Corya SA; Perlis RH; Keck PE; Lin DY; Case MG; Williamson DJ; Tohen MF
    J Clin Psychiatry; 2006 May; 67(5):798-806. PubMed ID: 16841630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrated analysis of olanzapine/fluoxetine combination in clinical trials of treatment-resistant depression.
    Trivedi MH; Thase ME; Osuntokun O; Henley DB; Case M; Watson SB; Campbell GM; Corya SA
    J Clin Psychiatry; 2009 Mar; 70(3):387-96. PubMed ID: 19284928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression.
    Corya SA; Williamson D; Sanger TM; Briggs SD; Case M; Tollefson G
    Depress Anxiety; 2006; 23(6):364-72. PubMed ID: 16710853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F; Berk M; Frye MA; Wang W; Barraco A; Tohen M
    J Clin Psychiatry; 2009 Oct; 70(10):1424-31. PubMed ID: 19906346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression--lack of manic induction.
    Amsterdam JD; Shults J
    J Affect Disord; 2005 Jul; 87(1):121-30. PubMed ID: 15923042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A preliminary, randomized trial of fluoxetine, olanzapine, and the olanzapine-fluoxetine combination in women with borderline personality disorder.
    Zanarini MC; Frankenburg FR; Parachini EA
    J Clin Psychiatry; 2004 Jul; 65(7):903-7. PubMed ID: 15291677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression.
    Brown EB; McElroy SL; Keck PE; Deldar A; Adams DH; Tohen M; Williamson DJ
    J Clin Psychiatry; 2006 Jul; 67(7):1025-33. PubMed ID: 16889444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of serotonin-related genes in antidepressant response.
    Peters EJ; Slager SL; McGrath PJ; Knowles JA; Hamilton SP
    Mol Psychiatry; 2004 Sep; 9(9):879-89. PubMed ID: 15052272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder.
    Brunner E; Tohen M; Osuntokun O; Landry J; Thase ME
    Neuropsychopharmacology; 2014 Oct; 39(11):2549-59. PubMed ID: 24801768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression.
    Keck PE; Corya SA; Altshuler LL; Ketter TA; McElroy SL; Case M; Briggs SD; Tohen M
    J Clin Psychiatry; 2005 May; 66(5):611-6. PubMed ID: 15889948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.
    Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A
    Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combining norepinephrine and serotonin reuptake inhibition mechanisms for treatment of depression: a double-blind, randomized study.
    Nelson JC; Mazure CM; Jatlow PI; Bowers MB; Price LH
    Biol Psychiatry; 2004 Feb; 55(3):296-300. PubMed ID: 14744472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Olanzapine/fluoxetine combination vs. lamotrigine in the 6-month treatment of bipolar I depression.
    Brown E; Dunner DL; McElroy SL; Keck PE; Adams DH; Degenhardt E; Tohen M; Houston JP
    Int J Neuropsychopharmacol; 2009 Jul; 12(6):773-82. PubMed ID: 19079815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial.
    Shi L; Namjoshi MA; Swindle R; Yu X; Risser R; Baker RW; Tohen M
    Clin Ther; 2004 Jan; 26(1):125-34. PubMed ID: 14996525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of regulatory TPH2 polymorphisms with higher reduction in depressive symptoms in children and adolescents treated with fluoxetine.
    Gassó P; Rodríguez N; Boloc D; Blázquez A; Torres T; Gortat A; Plana MT; Lafuente A; Mas S; Arnaiz JA; Lázaro L
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Jul; 77():236-240. PubMed ID: 28456685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.